Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-21-025787

Options or other derivatives

  • President, Ophthalmology & CMO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goldstein Michael H. · President, Ophthalmology & CMO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +250,000 250,000 D
Loading xslF345X03/tm217246d5_4seq1.xml…